17β-Estradiol upregulates the expression of peroxisome proliferator-activated receptor α and lipid oxidative genes in skeletal muscle

S. E. Campbell, K. A. Mehan, R. J. Tunstall, M. A. Febbraio, David Cameron-Smith

Research output: Contribution to journalArticleResearchpeer-review

55 Citations (Scopus)

Abstract

This study examined the actions of 17β-estradiol (E2) and progesterone on the regulation of the peroxisome proliferator-activated receptors (PPARα and PPARγ) family of nuclear transcription factors and the mRNA abundance of key enzymes involved in fat oxidation, in skeletal muscle. Specifically, carnitine palmitoyltransferase I (CPT I), β-3-hydroxyacyl CoA dehydrogenase (P-HAD), and pyruvate dehydrogenase kinase 4 (PDK4) were examined. Sprague-Dawley rats were ovariectomized and treated with placebo (Ovx), E2, progesterone, or both hormones in combination (E+P). Additionally, sham-operated rats were treated with placebo (Sham) to serve as controls. Hormone (or vehicle only) delivery was via time release pellets inserted at the time of surgery, 15 days prior to analysis. E2 treatment increased PPARα mRNA expression and protein content (P<0.05), compared with Ovx treatment. E2 also resulted in upregulated mRNA of CPT I and PDK4 (P<0.05), PPARγ mRNA expression was also increased (P<0.05) by E2 treatment, although protein content remained unaltered. These data demonstrate the novel regulation of E2 on PPARα and genes encoding key proteins that are pivotal in regulating skeletal muscle lipid oxidative flux.

Original languageEnglish
Pages (from-to)37-45
Number of pages9
JournalJournal of Molecular Endocrinology
Volume31
Issue number1
DOIs
Publication statusPublished - 1 Aug 2003
Externally publishedYes

Cite this

@article{a6049fa6349d4b5a83f7630a307e9a84,
title = "17β-Estradiol upregulates the expression of peroxisome proliferator-activated receptor α and lipid oxidative genes in skeletal muscle",
abstract = "This study examined the actions of 17β-estradiol (E2) and progesterone on the regulation of the peroxisome proliferator-activated receptors (PPARα and PPARγ) family of nuclear transcription factors and the mRNA abundance of key enzymes involved in fat oxidation, in skeletal muscle. Specifically, carnitine palmitoyltransferase I (CPT I), β-3-hydroxyacyl CoA dehydrogenase (P-HAD), and pyruvate dehydrogenase kinase 4 (PDK4) were examined. Sprague-Dawley rats were ovariectomized and treated with placebo (Ovx), E2, progesterone, or both hormones in combination (E+P). Additionally, sham-operated rats were treated with placebo (Sham) to serve as controls. Hormone (or vehicle only) delivery was via time release pellets inserted at the time of surgery, 15 days prior to analysis. E2 treatment increased PPARα mRNA expression and protein content (P<0.05), compared with Ovx treatment. E2 also resulted in upregulated mRNA of CPT I and PDK4 (P<0.05), PPARγ mRNA expression was also increased (P<0.05) by E2 treatment, although protein content remained unaltered. These data demonstrate the novel regulation of E2 on PPARα and genes encoding key proteins that are pivotal in regulating skeletal muscle lipid oxidative flux.",
author = "Campbell, {S. E.} and Mehan, {K. A.} and Tunstall, {R. J.} and Febbraio, {M. A.} and David Cameron-Smith",
year = "2003",
month = "8",
day = "1",
doi = "10.1677/jme.0.0310037",
language = "English",
volume = "31",
pages = "37--45",
journal = "Journal of Molecular Endocrinology",
issn = "0952-5041",
publisher = "Bioscientifica",
number = "1",

}

17β-Estradiol upregulates the expression of peroxisome proliferator-activated receptor α and lipid oxidative genes in skeletal muscle. / Campbell, S. E.; Mehan, K. A.; Tunstall, R. J.; Febbraio, M. A.; Cameron-Smith, David.

In: Journal of Molecular Endocrinology, Vol. 31, No. 1, 01.08.2003, p. 37-45.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - 17β-Estradiol upregulates the expression of peroxisome proliferator-activated receptor α and lipid oxidative genes in skeletal muscle

AU - Campbell, S. E.

AU - Mehan, K. A.

AU - Tunstall, R. J.

AU - Febbraio, M. A.

AU - Cameron-Smith, David

PY - 2003/8/1

Y1 - 2003/8/1

N2 - This study examined the actions of 17β-estradiol (E2) and progesterone on the regulation of the peroxisome proliferator-activated receptors (PPARα and PPARγ) family of nuclear transcription factors and the mRNA abundance of key enzymes involved in fat oxidation, in skeletal muscle. Specifically, carnitine palmitoyltransferase I (CPT I), β-3-hydroxyacyl CoA dehydrogenase (P-HAD), and pyruvate dehydrogenase kinase 4 (PDK4) were examined. Sprague-Dawley rats were ovariectomized and treated with placebo (Ovx), E2, progesterone, or both hormones in combination (E+P). Additionally, sham-operated rats were treated with placebo (Sham) to serve as controls. Hormone (or vehicle only) delivery was via time release pellets inserted at the time of surgery, 15 days prior to analysis. E2 treatment increased PPARα mRNA expression and protein content (P<0.05), compared with Ovx treatment. E2 also resulted in upregulated mRNA of CPT I and PDK4 (P<0.05), PPARγ mRNA expression was also increased (P<0.05) by E2 treatment, although protein content remained unaltered. These data demonstrate the novel regulation of E2 on PPARα and genes encoding key proteins that are pivotal in regulating skeletal muscle lipid oxidative flux.

AB - This study examined the actions of 17β-estradiol (E2) and progesterone on the regulation of the peroxisome proliferator-activated receptors (PPARα and PPARγ) family of nuclear transcription factors and the mRNA abundance of key enzymes involved in fat oxidation, in skeletal muscle. Specifically, carnitine palmitoyltransferase I (CPT I), β-3-hydroxyacyl CoA dehydrogenase (P-HAD), and pyruvate dehydrogenase kinase 4 (PDK4) were examined. Sprague-Dawley rats were ovariectomized and treated with placebo (Ovx), E2, progesterone, or both hormones in combination (E+P). Additionally, sham-operated rats were treated with placebo (Sham) to serve as controls. Hormone (or vehicle only) delivery was via time release pellets inserted at the time of surgery, 15 days prior to analysis. E2 treatment increased PPARα mRNA expression and protein content (P<0.05), compared with Ovx treatment. E2 also resulted in upregulated mRNA of CPT I and PDK4 (P<0.05), PPARγ mRNA expression was also increased (P<0.05) by E2 treatment, although protein content remained unaltered. These data demonstrate the novel regulation of E2 on PPARα and genes encoding key proteins that are pivotal in regulating skeletal muscle lipid oxidative flux.

UR - http://www.scopus.com/inward/record.url?scp=0041852780&partnerID=8YFLogxK

U2 - 10.1677/jme.0.0310037

DO - 10.1677/jme.0.0310037

M3 - Article

VL - 31

SP - 37

EP - 45

JO - Journal of Molecular Endocrinology

JF - Journal of Molecular Endocrinology

SN - 0952-5041

IS - 1

ER -